Business

VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

SAN JOSE, Calif., May 12, 2025--VSee Health, Inc. (the "Company") (Nasdaq: VSEE), announced today that on April 25, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"), the Company is not in compliance with Nasdaq’s listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Co

articleVsee Health, Inc.May 12, 20252/company/vsee-health-inc/news/vsee-health-inc-receives-nasdaq-notice-regarding-delayed-form-10-k-filing
VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

About this update from Vsee Health, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/4d902da7abf85fca8b142360c5d11493"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9DM4IBkUyHkNkkupJCBEpg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/4d902da7abf85fca8b142360c5d11493","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/HOhVQYNFulSiDD_GjvZfPQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/4d902da7abf85fca8b142360c5d11493","width":1024,"height":512}},"lazy":false},{"type":"text","content":"SAN JOSE, Calif., May 12, 2025--(BUSINESS WIRE)--VSee Health, Inc. (the "Company") (Nasdaq: VSEE), announced today that on April 25, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"), the Company is not in compliance with Nasdaq’s listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC").","length":578,"tagName":"p"},{"type":"text","content":"The Nasdaq notice has no immediate effect on the listing or trading of the Company’s common stock or its public warrants on The Nasdaq Capital Market. According to the notice, the Company has 60 calendar days until June 24, 2025 to submit to Nasdaq a plan to regain compliance. If Nasdaq accepts the Company’s plan, then Nasdaq may grant the Company up to 180 calendar days from the Form 10-K’s original due date, or until October 13, 2025, to regain compliance. The Company intends to take the necessary steps to regain compliance with Nasdaq’s listing rules and file the Form 10-K as soon as practicable.","length":606,"tagName":"p"},{"type":"text","content":"Forward-Looking Statements","length":26,"tagName":"p"},{"type":"text","content":"This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified ...

More updates from Vsee Health, Inc.

Nasdaqthe CompanyCompanyForward-Looking StatementsVSee Health, Inc.